Potency analysis of peptide, lysate and apoptotic cells as sources of tumor antigen(s) in dendritic cell-based vaccine immunotherapy in vivo.

被引：0
|
作者：
Shimizu, K
Kotera, Y
Mulé, JJ
机构：
[1] Tokyo Womens Med Coll, Sinjuku Ku, Tokyo 1662, Japan
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
FASEB JOURNAL | 2001年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1207 / A1207
页数：1
相关论文
共 50 条
  • [1] Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization
    Kotera, Y
    Shimizu, K
    Mulé, JJ
    CANCER RESEARCH, 2001, 61 (22) : 8105 - 8109
  • [2] Comparing tumor antigen specificity of lysate versus peptide-pulsed dendritic cell-based vaccines
    Maine, GN
    Mulé, JJ
    FASEB JOURNAL, 2002, 16 (04): : A334 - A334
  • [3] Development of dendritic cell-based immunotherapy using tumor endothelial cells as vaccine antigens
    Nomura, Tetsuya
    Utoguchi, Naoki
    CANCER SCIENCE, 2018, 109 : 1325 - 1325
  • [4] Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments
    Kang, Tae Heung
    Lee, Jin Hyup
    Bae, Hyun Cheol
    Noh, Kyung Hee
    Kim, Jin Hee
    Song, Chung Kil
    Shin, Byung Chul
    Hung, Chien-Fu
    Wu, T. -C.
    Park, Jong-Sup
    Kim, Tae Woo
    IMMUNOLOGY LETTERS, 2006, 106 (02) : 126 - 134
  • [5] Inhibition of TGF-β in tumor-draining lymph nodes can enhance the potency of dendritic cell-based vaccine immunotherapy
    Teramoto, Koji
    Fujita, Takuya
    Hanaoka, Jun
    Tezuka, Noriaki
    Kontani, Keiichi
    CANCER RESEARCH, 2012, 72
  • [6] NK Cells Are Required for Dendritic Cell-Based Immunotherapy at the Time of Tumor Challenge
    Bouwer, Anthea L.
    Saunderson, Sarah C.
    Caldwell, Felicity J.
    Damani, Tanvi T.
    Pelham, Simon J.
    Dunn, Amy C.
    Jack, Ralph W.
    Stoitzner, Patrizia
    McLellan, Alexander D.
    JOURNAL OF IMMUNOLOGY, 2014, 192 (05): : 2514 - 2521
  • [7] Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines
    Ruben, Jurjen M.
    van den Ancker, Willemijn
    Bontkes, Hetty J.
    Westers, Theresia M.
    Hooijberg, Erik
    Ossenkoppele, Gert J.
    de Gruijl, Tanja D.
    van de Loosdrecht, Arjan A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (04) : 335 - 345
  • [8] Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines
    Jurjen M. Ruben
    Willemijn van den Ancker
    Hetty J. Bontkes
    Theresia M. Westers
    Erik Hooijberg
    Gert J. Ossenkoppele
    Tanja D. de Gruijl
    Arjan A. van de Loosdrecht
    Cancer Immunology, Immunotherapy, 2014, 63 : 335 - 345
  • [9] GENERATION OF IMMUNOGENIC KILLED TUMOR CELLS FOR DENDRITIC CELL-BASED LUNG CANCER IMMUNOTHERAPY
    Adkins, I.
    Hradilova, N.
    Sadilkova, L.
    Truxova, I.
    Vancurova, I.
    Sojka, L.
    Fucikova, J. Palich
    Spisek, R.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S23 - S23
  • [10] The cancer-associated fibroblasts-targeted strategycan augment the potency of the dendritic cell-based vaccine immunotherapy.
    Ohshio, Yasuhiko
    Kaku, Ryosuke
    Ishida, Keiko
    Hashimoto, Masayuki
    Kitamura, Shoji
    Teramoto, Koji
    Hanaoka, Jun
    Tezuka, Noriaki
    CANCER RESEARCH, 2013, 73 (08)
12345